Science Explorer Interactive view Map
Company · Shanghai · China

Fosun Pharma (China)

fosunpharma.comROR OpenAlex
World rank, 2022–2025
#15,639
of 28,054 · #31,202 all time
Rank in China
#2,501
of 3,058
Research works
134
▲ 407% vs 2013–17
Citations
1.8k
13.5 per fractional work
Top-10% rate
18.4%
record average 16.5%
Open access
44%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.77× its world share, 2 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.04× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 5.82× its world share, 4 worksImmunology and Micro…Neuroscience: 0.63× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.13× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 0.34× its world share, 0 worksChemical EngineeringChemistry: 0.86× its world share, 1 worksChemistryComputer Science: 0.33× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.18× its world share, 0 worksEarth and Planetary …Energy: 0.13× its world share, 0 worksEnergyEngineering: 0.52× its world share, 6 worksEngineeringEnvironmental Science: 0.50× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.47× its world share, 1 worksMaterials ScienceMathematics: 0.70× its world share, 1 worksMathematicsDentistry: 0.53× its world share, 0 worksDentistryHealth Professions: 0.43× its world share, 1 worksHealth ProfessionsMedicine: 2.40× its world share, 32 worksMedicineNursing: 1.93× its world share, 1 worksNursingVeterinary: 1.18× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.07× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.38× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.04× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.8×. Every wedge is a field page.

Which keywords describe research at Fosun Pharma (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, Cancer, Inflammation, Breast Cancer, Tumor Microenvironment, Gene Therapy, Chemotherapy and Epidemiology.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer5▲ 5.4×26 topics
  2. Epidemiology5▲ 1.77×32 topics
  3. Inflammation5▲ 3.3×30 topics
  4. Cancer Therapy4▲ 11×11 topics
  5. Breast Cancer3▲ 19×5 topics
  6. Oxidative Stress3▲ 2.6×20 topics
  7. Chemotherapy3▲ 5.5×9 topics
  8. Immunotherapy3▲ 5.2×9 topics
  9. Tumor Microenvironment3▲ 8.5×6 topics
  10. Gene Therapy2▲ 18×6 topics
  11. Cell Death2▲ 12×4 topics
  12. Innate Immunity2▲ 8.5×7 topics
  13. Immune Response2▲ 4.5×7 topics
  14. Monoclonal Antibody2▲ 48×2 topics
  15. Prognostic Factors2▲ 6.0×9 topics
  16. Clinical Trials2▲ 3.6×6 topics
  17. Immunity2▲ 5.9×5 topics
  18. Metabolism2▲ 4.8×8 topics
  19. Metastatic Breast Cancer2▲ 44×2 topics
  20. Cancer Immunotherapy2▲ 15×3 topics
  21. Synthetic Lethality2▲ 69×2 topics
  22. Transcriptional Regulation2▲ 14×4 topics
  23. BRCA Mutation1▲ 89×1 topic
  24. DNA Repair1▲ 70×2 topics
  25. HER21▲ 71×1 topic
  26. Homologous Recombination1▲ 46×2 topics
  27. Inflammatory Diseases1▲ 11×5 topics
  28. PARP Inhibitors1▲ 89×1 topic
  29. Targeted Therapy1▲ 9.0×4 topics
  30. Therapy1▲ 10×3 topics
  31. Trastuzumab1▲ 45×1 topic
  32. Vaccine1▲ 5.1×5 topics
  33. Cell Cycle Control1▲ 63×2 topics
  34. Glycosylation1▲ 17×3 topics
  35. CDK4/6 Inhibitors1▲ 67×1 topic
  36. Palbociclib1▲ 67×1 topic
  37. Signal Transduction1▲ 12×4 topics
  38. Therapeutic Targets1▲ 11×5 topics
  39. Lymphoma1▲ 10×2 topics
  40. Macular Degeneration1▲ 13×3 topics

Which research topics does Fosun Pharma (China) publish most on?

By volume in 2022–2025: HER2/EGFR in Cancer Research, PARP inhibition in cancer therapy, Advanced Breast Cancer Therapies and Cancer Immunotherapy and Biomarkers.

HER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksPARP inhibition in cance…1PARP inhibition in cancer therapy: 1 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCAR-T cell therapy research: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksFibroblast Growth Factor…1Fibroblast Growth Factor Research: 1 fractional worksMelanoma and MAPK Pathways: 1 fractional worksRNA Interference and Gene Delivery: 1 fractional works
OncologyPulmonary and Respiratory MedicineMolecular Biology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 HER2/EGFR in Cancer Research Oncology 1 works
  2. 2 PARP inhibition in cancer therapy Oncology 1 works
  3. 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 1 works
  5. 5 CAR-T cell therapy research Oncology 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 1 works
  7. 7 Peptidase Inhibition and Analysis Oncology 1 works
  8. 8 Fibroblast Growth Factor Research Molecular Biology 1 works
  9. 9 Melanoma and MAPK Pathways Molecular Biology 1 works
  10. 10 RNA Interference and Gene Delivery Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.2%not open55.8%

World: 28% of research is openly available.

with international co-authors23.1%domestic only76.9%

World: 19% is written across borders.

How has Fosun Pharma (China)'s research output changed?

Output in 2018–2022 was 407% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shanghai

All research institutions in Shanghai

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.